Plasma amino acid differences in very low birth weight infants fed either human milk or whey-dominant cow milk

Insights

Very low birth weight infants fed whey-dominant formula had higher essential amino acid plasma levels. Fortified human milk supported higher taurine and cystine concentrations, suggesting formula modifications may be needed.

Area of Science:

  • Neonatal nutrition
  • Biochemistry
  • Pediatric gastroenterology

Background:

  • Optimal nutrition is critical for very low birth weight (VLBW) infants' growth and development.
  • Enteral feeding strategies significantly impact nutrient absorption and plasma amino acid profiles.
  • Human milk and specialized formulas offer different nutritional compositions.

Purpose of the Study:

  • To compare plasma amino acid levels in VLBW infants fed fortified human milk versus whey-dominant cow milk-based formula.
  • To assess the impact of different enteral nutrition sources on nitrogen utilization and growth parameters.
  • To identify potential differences in amino acid profiles that may inform formula development.

Main Methods:

  • 31 healthy VLBW infants (gestation 29 wk, birth weight 1180 g) participated in 96-hour balance studies.
  • Infants received continuous enteral infusions of either fortified human milk (n=18) or whey-dominant cow milk formula (n=13).
  • Midmorning plasma amino acid levels, weight gain, nitrogen retention, and metabolizable energy were measured and compared between groups.

Main Results:

  • Weight gain, nitrogen retention, and metabolizable energy were similar between the two feeding groups.
  • Infants fed whey-dominant formula showed significantly higher plasma levels of threonine, valine, and total essential amino acids (p<0.01).
  • Fortified human milk resulted in significantly higher plasma concentrations of taurine and cystine (p<0.01), while whey-dominant formula showed higher threonine, valine, methionine, and lysine (p<0.01).

Conclusions:

  • While growth parameters were comparable, significant differences exist in plasma amino acid profiles between VLBW infants fed fortified human milk and whey-dominant formula.
  • The distinct amino acid profiles suggest that current whey-dominant formulas may require further modifications to better mimic human milk composition.
  • Understanding these differences is crucial for optimizing nutritional strategies and improving outcomes for VLBW infants.

Related Concept Videos

Drug Distribution: Plasma Protein Binding01:29

Drug Distribution: Plasma Protein Binding

Drugs predominantly attach to plasma proteins, with only a small percentage remaining unbound. The unbound portion can be calculated as one minus the bound fraction. Acidic drugs form large, inactive complexes by reversibly binding to plasma albumin, which prevents them from diffusing across biological barriers. These drug-protein complexes act as reservoirs for the drugs. As the concentration of unbound drugs decreases, these complexes quickly dissociate to release the free drug, maintaining...
Overview of Protein Metabolism01:21

Overview of Protein Metabolism

Proteins are broken down into amino acids during digestion. Unlike fats and carbohydrates, which are stored for later use, proteins are not. Instead, amino acids are either used to produce ATP through oxidation or contribute to the creation of new proteins for the growth and repair of the body. Any surplus amino acids from the diet are converted into glucose or triglycerides rather than excreted.
Amino acids play various roles in the body once they are absorbed into cells. They are restructured...
Pharmacokinetics in Pediatric Patients: Overview and Drug Absorption01:23

Pharmacokinetics in Pediatric Patients: Overview and Drug Absorption

Understanding the physiological differences in the pediatric population is crucial for effective pharmacotherapy. Neonates, infants, and children exhibit significant variations in gastric pH, gastric emptying time, intestinal transit time, and biliary function. These variations profoundly affect oral drug absorption, necessitating a nuanced approach to pediatric dosing.Neonates present with a unique physiological profile, having a gastric pH greater than 4 and faster and more irregular gastric...
Pharmacokinetics in Pediatric Patients: Drug Distribution01:17

Pharmacokinetics in Pediatric Patients: Drug Distribution

Drug distribution in the pediatric population exhibits unique challenges and considerations due to the physiological differences between children, particularly neonates and infants, and adults. A crucial aspect of pediatric pharmacology is understanding how these differences impact the pharmacokinetics of various drugs, necessitating age-specific dosing strategies to ensure efficacy and safety.Neonates and infants have a higher total body water content, ~75%–90% of their body weight, compared...
Development of Human Microbiota01:30

Development of Human Microbiota

The human microbiota begins developing at birth and undergoes continual change as we age. Infancy marks a critical period of microbial sensitivity, offering a “window of opportunity” during which beneficial microbes help mature the immune system. By age three, children typically develop a more stable and diverse microbial community. Newborns acquire microbes from their immediate environment; vaginal delivery favors maternal vaginal microbes, while cesarean births favor microbes from the skin...
Taste During Infancy01:20

Taste During Infancy

The sense of taste begins developing before birth and is shaped by biological predispositions and early experience. During pregnancy, flavors from foods consumed by the mother can enter the amniotic fluid, exposing the fetus to different flavors. These prenatal experiences may contribute to food preferences after birth.Prenatal and Breastfeeding InfluencesAfter birth, flavors from a mother’s diet can also pass into breast milk. Repeated exposure to these flavors during breastfeeding may make...